Navigating the 340B Program Amidst Policy Shifts matters because it changes what a BCBA notices when decisions have to hold up in clinical documentation, payer communication, supervision records, and leadership review. In Navigating the 340B Program Amidst Policy Shifts, for this course, the practical stakes show up in service continuity, accurate reporting, and defensible clinical decisions, not in abstract discussion alone.
Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →The 340B program is at the center of a fierce debate, drawing unprecedented attention from policymakers in Washington, D.C., and across the states. Drug manufacturers are aggressively restricting access to discounts in the contract pharmacy setting, while the federal government and a growing number of states are pushing back. This politically charged program raises contentious issues with some opponents alleging abuse by large health systems, lack of transparency in savings and use by undocumented immigrants. Proponents argue that 340B is a lifeline for providers serving vulnerable patients, providing essential medications and other services at reduced costs. With Congress proposing new legislation and states leading the charge against restrictive measures, the battle lines are drawn. Multiple lawsuits by pharmaceutical companies are unfolding, and the new Medicare drug program looms large, which could have a significant impact on the program. Join our panel for a no-holds-barred discussion on these critical issues. We'll explore the profound impact on patients, the implications for various stakeholders, and make bold predictions on the outcomes of ongoing and future decisions. Whether you see the 340B program as a savior or a scourge, this is a conversation you won't want to miss.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Ted Slafsky is Publisher and Chief Executive Officer of 340B Report, the only news and intelligence service focused exclusively on the 340B program. Slafsky is also Founder & Principal of theboutique consulting firm Wexford Solutions. He has over three decades of experience in the 340B program and journalism. Prior to 340B Report, he served as the long time President & CEO of 340B Health, a Washington D.C.-based association of over 1500 hospitals and health systems in the 340B program. He began his career as an award-winning reporter and researcher at U.S News & World Report and then served as a health policy fellow in the U.S. Senate. Slafsky received his Bachelor’s degree from Tufts University and Master of Public Policy from Duke University.
Dig into the research behind this topic — plain-English summaries written for BCBAs.
233 research articles with practitioner takeaways
231 research articles with practitioner takeaways
225 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.